10 Medicine name Potential for harm identified International Sept sAXagliptin added to Tall Man Considered by expert advisory panel. pair: saxagliptin internationally by ISMP and listing 2017 Lettering List 2017 BISIM and risk assessment result and sitagliptin medicines available in demonstrated a medium to high risk Australia (no known of confusion. Application of Tall Man lettering incidents reported). These adjusted: agents are same class of siTagliptin (changed from sITAGLIPTIn) medicine. Sitagliptin already listed. 11 Medicine name Potential for harm identified International Sept Added to Tall Man Lettering List 2017 Considered by expert advisory pair: aripiprazole internationally by ISMP and listing 2017 and risk assessment result and rabeprazole medicines available in demonstrated a medium to high risk Australia (no known of confusion. incidents reported).
10 Medicine name pair: saxagliptin and sitagliptin Potential for harm identified internationally by ISMP and medicines available in Australia (no known incidents reported). These agents are same class of medicine. Sitagliptin already listed. International listing Sept 2017 sAXagliptin added to Tall Man Lettering List 2017 Application of Tall Man lettering adjusted: siTagliptin (changed from sITAGLIPTIn) Considered by expert advisory panel. BISIM and risk assessment result demonstrated a medium to high risk of confusion. 11 Medicine name pair: aripiprazole and rabeprazole Potential for harm identified internationally by ISMP and medicines available in Australia (no known incidents reported). International listing Sept 2017 Added to Tall Man Lettering List 2017 Considered by expert advisory and risk assessment result demonstrated a medium to high risk of confusion.